SCHEMBL15280576

SCHEMBL15280576

CON(C)C(=O)[C@@H]1Cc2ccccc2N1S(=O)(=O)c1cccc2c(N(C)C)cccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.45
ATM Q13315 1/20 0.45
F2 P00734 2/20 0.42
PRSS1 P07477 2/20 0.42
PRSS2 P07478 2/20 0.42
PRSS3 P35030 2/20 0.42
HTR1A P08908 4/20 0.41
HTR6 P50406 3/20 0.40
CA2 P00918 1/20 0.39
NPC1 O15118 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
THPO P40225 1/20 0.39
MTOR P42345 1/20 0.39
RAB9A P51151 1/20 0.39
HIF1A Q16665 1/20 0.39
HSD17B10 Q99714 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15280426 0.87 KMT2A (0.49) KMT2AATMF2PRSS1PRSS2
SCHEMBL16450985 0.87 KMT2A (0.49) KMT2AATMF2PRSS1PRSS2
SCHEMBL18041155 0.87 KMT2A (0.49) KMT2AATMF2PRSS1PRSS2
SCHEMBL15280559 0.87 KMT2A (0.49) KMT2AATMF2PRSS1PRSS2
SCHEMBL15280425 0.87 KMT2A (0.49) KMT2AATMF2PRSS1PRSS2
SCHEMBL16450979 0.87 KMT2A (0.49) KMT2AATMF2PRSS1PRSS2
SCHEMBL18041154 0.87 KMT2A (0.49) KMT2AATMF2PRSS1PRSS2
SCHEMBL20920600 0.80 KMT2A (0.41) KMT2AATMF2PRSS1PRSS2
SCHEMBL18041160 0.78 TGM2 (0.47) KMT2AHTR1AHTR6NPC1TP53
SCHEMBL18041159 0.78 TGM2 (0.47) KMT2AHTR1AHTR6NPC1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10266490-B2 Radioprotector compounds GEORGETOWN UNIVERSITY (US) 2019-04-23 US disclosed
US-20150044293-A1 RADIOPROTECTOR COMPOUNDS GEORGETOWN UNIVERSITY (US) 2015-02-12 US disclosed
US-20150044293-A1 RADIOPROTECTOR COMPOUNDS GEORGETOWN UNIVERSITY (US) 2015-02-12 US disclosed
WO-2013138600-A1 RADIOPROTECTOR COMPOUNDS ROSEN ELIOT M (US) 2013-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10266490-B2 Radioprotector compounds DDB1, CASP3, BAD KMT2A 3092/4885ATM 420/4885F2 4166/4885
US-20150044293-A1 RADIOPROTECTOR COMPOUNDS DDB1, CASP3, BAD KMT2A 3092/4885ATM 420/4885F2 4166/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.